Characterization of a novel HIV-1 circulating recombinant form, CRF91_cpx, comprising CRF02_AG, G, J, and U, mostly among men who have sex with men

References

• The HIV-CAUSAL Collaboration. The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals. Aids. 2010;24:123–137.
   PubMed Web of Science ®Google Scholar
• UNAIDS. Global HIV & AIDS statistics — Fact sheet [Internet]. 2021.
   Google Scholar
• European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe. HIV/AIDS surveillance in Europe 2020 data. 2021.
   Google Scholar
• Pineda-Peña A-C, Theys K, Stylianou DC, et al. HIV-1 infection in Cyprus, the eastern Mediterranean European frontier: A densely sampled transmission dynamics analysis from 1986 to 2012. Sci Rep. 2018;8:1702.
   PubMed Web of Science ®Google Scholar
• Robertson DL, Anderson JP, Bradac JA, et al. HIV-1 nomenclature proposal. Science. 2000;288:55–56.
   PubMed Web of Science ®Google Scholar
• Yamaguchi J, Vallari A, McArthur C, et al. Brief report: Complete Genome sequence of CG-0018a-01 establishes HIV-1 Subtype L. J Acquir Immune Defic Syndr. 2020;83:319–322.
   PubMed Web of Science ®Google Scholar
• Robertson DL, Hahn BH, Sharp PM. Recombination in AIDS viruses. J Mol Evol. 1995;40:249–259.
   PubMed Web of Science ®Google Scholar
• McCutchan FE. Global epidemiology of HIV. J Med Virol. 2006;78(Suppl 1):S7–12.
   PubMedGoogle Scholar
• Bbosa N, Kaleebu P, Ssemwanga D. HIV subtype diversity worldwide. Curr Opin HIV AIDS. 2019;14:153–160.
   PubMed Web of Science ®Google Scholar
• Peeters M.Recombinant HIV sequences: Their role in the global epidemic. 2000;54–72. https://www.hiv.lanl.gov/content/immunology/pdf/2000/1/Peeters.pdf
   Google Scholar
• Kostrikis LG, Hezka J, Stylianou DC, et al. HIV-1 transmission networks across Cyprus (2010-2012). PLoS One. 2018;13:e0195660.
   PubMed Web of Science ®Google Scholar
• Gao F, Robertson DL, Carruthers CD, et al. An isolate of human immunodeficiency virus type 1 originally classified as subtype I represents a complex mosaic comprising three different group M subtypes (A, G, and I). J Virol. 1998;72:10234–10241.
   PubMed Web of Science ®Google Scholar
• Paraskevis D, Magiorkinis M, Vandamme AM, et al. Re-Analysis of human immunodeficiency virus type 1 isolates from Cyprus and Greece, initially designated “subtype I”, reveals a unique complex A/G/H/K/? mosaic pattern. J Gen Virol. 2001;82:575–580.
   PubMed Web of Science ®Google Scholar
• Kousiappa I, De Vijver DAMC V, Kostrikis LG. Near full-length genetic analysis of HIV sequences derived from Cyprus: Evidence of a highly polyphyletic and evolving infection. AIDS Res Hum Retroviruses. 2009;25:727–740.
   PubMed Web of Science ®Google Scholar
• Kousiappa I, Achilleos C, Hezka J, et al. Molecular characterization of HIV type 1 strains from newly diagnosed patients in Cyprus (2007-2009) recovers multiple clades including unique recombinant strains and lack of transmitted drug resistance. AIDS Res Hum Retroviruses. 2011;27:1183–1199.
   PubMed Web of Science ®Google Scholar
• Kousiappa I, van de Vijver DAMC, Demetriades I, et al. Genetic analysis of HIV type 1 strains from newly infected untreated patients in Cyprus: High genetic diversity and low prevalence of drug resistance. AIDS Res Hum Retroviruses. 2009;25:23–35.
   PubMed Web of Science ®Google Scholar
• Chrysostomou AC, Topcu C, Stylianou DC, et al. Development of a new comprehensive HIV-1 genotypic drug resistance assay for all commercially available reverse transcriptase, protease and integrase inhibitors in patients infected with group M HIV-1 strains. Infect Genet Evol. 2020;81:104243.
   PubMed Web of Science ®Google Scholar
• Pineda-Peña A-C, Faria NR, Imbrechts S, et al. Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: Performance evaluation of the new REGA version 3 and seven other tools. Infect Genet Evol. 2013;19:337–348.
   PubMed Web of Science ®Google Scholar
• Kumar S, Stecher G, Li M, et al. MEGA X: Molecular evolutionary genetics analysis across computing platforms. Mol Biol Evol. 2018;35:1547–1549.
   PubMed Web of Science ®Google Scholar
• Ragonnet-Cronin M, Hodcroft E, Hué S, et al. Automated analysis of phylogenetic clusters. BMC Bioinformatics. 2013;14:317.
   PubMed Web of Science ®Google Scholar
• Rambaut A FigTree v1.4.3. [Internet]. 2016;
   Google Scholar
• Lole KS, Bollinger RC, Paranjape RS, et al. Full-Length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol. 1999;73:152–160.
   PubMed Web of Science ®Google Scholar
• Schultz A, Zhang M, Bulla I, Leitner T, Korber B, Morgenstern B and Stanke M. (2009). jpHMM: Improving the reliability of recombination prediction in HIV-1. Nucleic Acids Research, 37(Web Server), W647–W651. DOI:10.1093/nar/gkp371.
   PubMedGoogle Scholar
• Siepel AC, Halpern AL, Macken C, et al. A computer program designed to screen rapidly for HIV type 1 intersubtype recombinant sequences. AIDS Res Hum Retroviruses. 1995;11:1413–1416.
   PubMed Web of Science ®Google Scholar
• Nguyen L-T, Schmidt HA, von Haeseler A, et al. IQ-TREE: A fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies. Mol Biol Evol. 2015;32:268–274.
   PubMed Web of Science ®Google Scholar
• Guindon S, Dufayard J-F, Lefort V, et al. New algorithms and methods to estimate maximum-likelihood phylogenies: Assessing the performance of PhyML 3.0. Syst Biol. 2010;59:307–321.
   PubMed Web of Science ®Google Scholar
• EuroGuidelines Group for HIV Resistance. Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: Recommendations for the European setting. The EuroGuidelines Group for HIV resistance. Aids. 2001;15:309–320.
   PubMed Web of Science ®Google Scholar
• Ng’Uni T, Chasara C, Ndhlovu ZM. Major scientific hurdles in HIV vaccine development: Historical perspective and future directions. Front Immunol. 2020;11:11.
   PubMed Web of Science ®Google Scholar
• Tang M W, Liu T F and Shafer R W. (2012). The HIVdb System for HIV-1 Genotypic Resistance Interpretation. Intervirology, 55(2), 98–101. DOI:10.1159/000331998.
   PubMed Web of Science ®Google Scholar
• Billings E, Kijak GH, Sanders-Buell E, et al. New subtype B containing HIV-1 circulating recombinant of sub-Saharan Africa Origin in Nigerian men who have sex with men. J Acquir Immune Defic Syndr. 2019;81:578–584.
   PubMed Web of Science ®Google Scholar
• Ajoge HO, Gordon ML, Ibrahim S, et al. Drug resistance pattern of HIV type 1 isolates sampled in 2007 from therapy-naive pregnant women in North-Central Nigeria. AIDS Res Hum Retroviruses. 2012;28:115–118.
   PubMed Web of Science ®Google Scholar
• Charurat M, Nasidi A, Delaney K, et al. Characterization of acute HIV-1 infection in high-risk Nigerian populations. J Infect Dis. 2012;205:1239–1247.
   PubMed Web of Science ®Google Scholar
• Imade GE, Sagay AS, Chaplin B, et al. Short communication: Transmitted HIV drug resistance in antiretroviral-naive pregnant women in north central Nigeria. AIDS Res Hum Retroviruses. 2014;30:127–133.
   PubMed Web of Science ®Google Scholar
• Nazziwa J, Faria NR, Chaplin B, et al. Characterisation of HIV-1 molecular epidemiology in Nigeria: Origin, diversity, demography and geographic spread. Sci Rep. 2020;10:3468.
   PubMed Web of Science ®Google Scholar
• El Bouzidi K, Datir RP, Kwaghe V, et al. Deep sequencing of HIV-1 reveals extensive subtype variation and drug resistance after failure of first-line antiretroviral regimens in Nigeria. J Antimicrob Chemother. 2022;77:474–482.
   PubMed Web of Science ®Google Scholar